To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes
Örebro University, School of Medical Sciences.ORCID iD: 0000-0003-1025-1682
Technical University Dresden, Dresden, Germany.
Southern New Hampshire Diabetes and Endocrinology, Nashua NH, USA.
CSHP / DaVita Clinical Research, Colorado Springs CO, USA.
Show others and affiliations
2017 (English)In: Value in Health, ISSN 1098-3015, E-ISSN 1524-4733, Vol. 20, no 9, p. A484-A484Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Elsevier, 2017. Vol. 20, no 9, p. A484-A484
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-63341DOI: 10.1016/j.jval.2017.08.481ISI: 000413599900456OAI: oai:DiVA.org:oru-63341DiVA, id: diva2:1165487
Available from: 2017-12-13 Created: 2017-12-13 Last updated: 2019-06-11Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records

Jendle, Johan

Search in DiVA

By author/editor
Jendle, Johan
By organisation
School of Medical Sciences
In the same journal
Value in Health
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 333 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf